MyFinsight
Home
Blog
About
Contact
Back
Income Statement
ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. (SPRY)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$60,839K
(-78.48%↓ Y/Y)
Net loss
-$60,618K
(-78.60%↓ Y/Y)
Unrealized gaines on
available-for-sale securities
-$221K
(-49.32%↓ Y/Y)
Product
$17,452K
(124.81%↑ Y/Y)
Revenue Under Supply
Agreements
$2,740K
Revenue Under
Collaboration Agreements
$2,489K
(1085.24%↑ Y/Y)
Loss from operations
-$60,145K
(-61.78%↓ Y/Y)
Total other (expense)
income, net
-$473K
(-114.61%↓ Y/Y)
Total revenue
$22,681K
(184.47%↑ Y/Y)
Interest income
$1,968K
Total operating
expenses
$82,826K
(83.45%↑ Y/Y)
Interest expense
(including related party...
$2,441K
Selling, general and
administrative (including...
$72,204K
(75.66%↑ Y/Y)
Cost of goods sold
(including related party...
$6,286K
(474.59%↑ Y/Y)
Research and development
(including related party...
$4,336K
(46.88%↑ Y/Y)
Back